A Phase II trial of 8 weeks of degarelix for prostate volume reduction: Efficacy and hormonal recovery.
Sign Up to like & getrecommendations! Published in 2018 at "Brachytherapy"
DOI: 10.1016/j.brachy.2017.12.005
Abstract: PURPOSE The purpose of this study was to determine the efficacy of 8 weeks of degarelix for prostate downsizing before interstitial brachytherapy. We also report associated toxicity and the time course of endocrine recovery over… read more here.
Keywords: recovery; weeks degarelix; volume; degarelix prostate ... See more keywords